Healthcare provider profile · identity verified

Luis R Padron, MD

Internal Medicine · MIAMI, FL · NPI 1801865076

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	472	137
Levothyroxine Sodium	Levothyroxine Sodium	416	107
Atorvastatin Calcium	Atorvastatin Calcium	411	117
Metoprolol Succinate	Metoprolol Succinate	331	95
Pantoprazole Sodium	Pantoprazole Sodium	324	101
Famotidine	Famotidine	288	91
Omeprazole	Omeprazole	247	73
Memantine Hcl	Memantine Hcl	242	70
Amlodipine Besylate	Amlodipine Besylate	214	64
Losartan Potassium	Losartan Potassium	198	58
Gabapentin	Gabapentin	194	59
Furosemide	Furosemide	182	59
Azithromycin	Azithromycin	170	123
Metformin Hcl Er	Metformin Hcl	148	31
Sertraline Hcl	Sertraline Hcl	148	40
Escitalopram Oxalate	Escitalopram Oxalate	140	44
Montelukast Sodium	Montelukast Sodium	134	38
Buspirone Hcl	Buspirone Hcl	131	42
Fluticasone Propionate	Fluticasone Propionate	130	70
Quetiapine Fumarate	Quetiapine Fumarate	116	31
Trazodone Hcl	Trazodone Hcl	115	31
Tamsulosin Hcl	Tamsulosin Hcl	102	32
Allopurinol	Allopurinol	101	25
Olmesartan Medoxomil	Olmesartan Medoxomil	100	28
Eliquis	Apixaban	99	20
Lactulose	Lactulose	89	30
Carvedilol	Carvedilol	88	26
Duloxetine Hcl	Duloxetine Hcl	88	26
Donepezil Hcl	Donepezil Hcl	86	23
Mirtazapine	Mirtazapine	85	29
Citalopram Hbr	Citalopram Hydrobromide	83	25
Ozempic	Semaglutide	80	12
Clopidogrel	Clopidogrel Bisulfate	79	24
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	77	35
Meloxicam	Meloxicam	77	49
Valsartan	Valsartan	75	23
Farxiga	Dapagliflozin Propanediol	74	15
Methylprednisolone	Methylprednisolone	74	60
Pravastatin Sodium	Pravastatin Sodium	74	25
Pregabalin	Pregabalin	71	17
Synthroid	Levothyroxine Sodium	68	18
Telmisartan	Telmisartan	68	19
Bumetanide	Bumetanide	67	19
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	67	49
Lisinopril	Lisinopril	66	18
Baclofen	Baclofen	64	30
Glimepiride	Glimepiride	64	17
Doxazosin Mesylate	Doxazosin Mesylate	63	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	63	16
Potassium Chloride	Potassium Chloride	63	17
Livalo	Pitavastatin Calcium	62	17
Simvastatin	Simvastatin	60	15
Hydrochlorothiazide	Hydrochlorothiazide	58	25
Glipizide Er	Glipizide	54	16
Paroxetine Hcl	Paroxetine Hcl	53	14
Ezetimibe	Ezetimibe	52	19
Hydralazine Hcl	Hydralazine Hcl	50	14
Meclizine Hcl	Meclizine Hcl	50	19
Metformin Hcl	Metformin Hcl	50	17
Glipizide	Glipizide	49	15
Irbesartan	Irbesartan	49	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	49	11
Spironolactone	Spironolactone	48	14
Ssd	Silver Sulfadiazine	48	31
Prednisone	Prednisone	47	21
Tramadol Hcl	Tramadol Hcl	47	15
Clonazepam	Clonazepam	45	suppressed
Folic Acid	Folic Acid	44	17
Pioglitazone Hcl	Pioglitazone Hcl	43	12
Cefuroxime	Cefuroxime Axetil	40	31
Metoprolol Tartrate	Metoprolol Tartrate	40	18
Nifedipine Er	Nifedipine	40	16
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	39	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	12
Vitamin D2	Ergocalciferol (Vitamin D2)	38	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	36	suppressed
Entresto	Sacubitril/Valsartan	36	12
Solifenacin Succinate	Solifenacin Succinate	34	16
Temazepam	Temazepam	33	suppressed
Repatha Sureclick	Evolocumab	32	suppressed
Clonidine Hcl	Clonidine Hcl	31	14
Ammonium Lactate	Ammonium Lactate	30	11
Atenolol	Atenolol	30	11
Diclofenac Sodium	Diclofenac Sodium	30	15
Finasteride	Finasteride	28	12
Nexletol	Bempedoic Acid	28	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	26	suppressed
Hydrocortisone	Hydrocortisone	26	12
Sildenafil Citrate	Sildenafil Citrate	26	suppressed
Alprazolam	Alprazolam	25	14
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Tresiba Flextouch U-100	Insulin Degludec	25	suppressed
Celecoxib	Celecoxib	24	12
Dicyclomine Hcl	Dicyclomine Hcl	24	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	17
Jardiance	Empagliflozin	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Ramipril	Ramipril	21	suppressed
Torsemide	Torsemide	21	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	19	suppressed
Clotrimazole	Clotrimazole	18	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	18	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Lovastatin	Lovastatin	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Sodium Polystyrene Sulfonate	Sodium Polystyrene Sulfonate	16	suppressed
Clonidine	Clonidine	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Digoxin	Digoxin	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Metronidazole	Metronidazole	14	13
Tobramycin	Tobramycin	14	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Telmisartan-Amlodipine	Telmisartan/Amlodipine	13	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Cephalexin	Cephalexin	11	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	11	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	11	suppressed
Risperidone	Risperidone	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error